These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 9182841)
1. In vitro antitumor activity of 3'-desamino-3'(2-methoxy-4-morpholinyl) doxorubicin on human melanoma cells sensitive or resistant to triazene compounds. Alvino E; Gilberti S; Cantagallo D; Massoud R; Gatteschi A; Tentori L; Bonmassar E; D'Atri S Cancer Chemother Pharmacol; 1997; 40(2):180-4. PubMed ID: 9182841 [TBL] [Abstract][Full Text] [Related]
2. Changes of immunological patterns of human cancer cells treated in vitro with a triazene compound. D'Atri S; Ballerini P; Fuggetta MP; Faggioni A; Piazza A; Giuliani A Immunopharmacol Immunotoxicol; 1989; 11(1):101-18. PubMed ID: 2547862 [TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering? Serafino A; Sinibaldi-Vallebona P; Pierimarchi P; Bernard P; Gaudiano G; Massa C; Rasi G; Ranagnan G Anticancer Res; 1999; 19(3A):1909-18. PubMed ID: 10470135 [TBL] [Abstract][Full Text] [Related]
4. Drug-mediated changes in the susceptibility of human lymphoblastoid B cells to NK-mediated cytolysis: studies with a triazene compound. D'Atri S; Bonmassar L; Turriziani M; Giuliani A J Chemother; 1994 Oct; 6(5):328-36. PubMed ID: 7532216 [TBL] [Abstract][Full Text] [Related]
5. In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. Fuggetta MP; D'Atri S; Lanzilli G; Tricarico M; Cannavò E; Zambruno G; Falchetti R; Ravagnan G Melanoma Res; 2004 Jun; 14(3):189-96. PubMed ID: 15179187 [TBL] [Abstract][Full Text] [Related]
6. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875 [TBL] [Abstract][Full Text] [Related]
7. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin. Jain N; Lam YM; Pym J; Campling BG Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677 [TBL] [Abstract][Full Text] [Related]
9. Resistance of human melanoma cells against the cytotoxic and complement-enhancing activities of doxorubicin. Panneerselvam M; Bredehorst R; Vogel CW Cancer Res; 1987 Sep; 47(17):4601-7. PubMed ID: 3621156 [TBL] [Abstract][Full Text] [Related]
10. Differential changes in purine nucleotides after Doxorubicin treatment of human cancer cells in vitro. Walenta S; Feigk B; Wachsmuth I; Dunkern T; Degani H; Mueller-Klieser W Int J Oncol; 2002 Aug; 21(2):289-96. PubMed ID: 12118323 [TBL] [Abstract][Full Text] [Related]
11. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Lau DH; Lewis AD; Ehsan MN; Sikic BI Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140 [TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase and glutathione peroxidase are essential in the early stage of adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells. Lee WP; Lee CL; Lin HC Cancer Chemother Pharmacol; 1996; 38(1):45-51. PubMed ID: 8603451 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and in Vitro cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6-diazacyclopenta[b]anthracene-5,10-diones. Kwak JH; Namgoong K; Jung JK; Han SB; Cho J; Kim HM; Park SG; Lee K; Kang JS; Lee H Arch Pharm Res; 2010 May; 33(5):663-7. PubMed ID: 20512462 [TBL] [Abstract][Full Text] [Related]
16. Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer--a possible indicator of chemosensitivity. Lee FY; Siemann DW; Sutherland RM Br J Cancer; 1989 Sep; 60(3):291-8. PubMed ID: 2789934 [TBL] [Abstract][Full Text] [Related]
17. In vitro combined effects of a triazene compound and interferon-beta on natural immunity against lymphoblastoid cells: studies at effector and target cell level. Bonmassar L; D'Atri S; Turriziani M; Giuliani A Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):695-715. PubMed ID: 7876468 [TBL] [Abstract][Full Text] [Related]